Aspartate N-acetyltransferase (NAT8L, N-acetyltransferase 8-like), the enzyme that synthesizes N-acetylaspartate, is membrane-bound and is at least partially associated with the ER (endoplasmic reticulum). The aim of the present study was to determine which regions of the protein are important for its catalytic activity and its subcellular localization. Transfection of truncated forms of NAT8L into HEK (human embryonic kidney)-293T cells indicated that the 68 N-terminal residues (regions 1 and 2) have no importance for the catalytic activity and the subcellular localization of this enzyme, which was exclusively associated with the ER. Mutation of conserved residues that precede (Arg 81 and Glu 101 , in region 3) or follow (Asp 168 and Arg 220 , in region 5) the putative membrane region (region 4) markedly affected the kinetic properties, suggesting that regions 3 and 5 form the catalytic domain and that the membrane region has a loop structure. Evidence is provided for the membrane region comprising α-helices and the catalytic site being cytosolic. Transfection of chimaeric proteins in which GFP (green fluorescent protein) was fused to different regions of NAT8L indicated that the membrane region (region 4) is necessary and sufficient to target NAT8L to the ER. Thus NAT8L is targeted to the ER membrane by a hydrophobic loop that connects two regions of the catalytic domain.
INTRODUCTION
N-acetylaspartate is an abundant brain molecule, especially in neurons where its concentration reaches ∼ 20 mM, yet its function is still elusive. Its abundance allows one to determine its concentration in vivo by magnetic resonance spectroscopy. This measure is taken to reflect the amount and 'health' of neurons, and is therefore useful for the diagnosis of several neurological disorders (reviewed in [1] ). N-acetylaspartate is synthesized from acetyl-CoA and L-aspartate by a membrane-bound enzyme [2] [3] [4] , which is inactive in the presence of high concentrations of detergents [5] and therefore cannot be purified. This enzyme has been reported to be associated with microsomes [4, 6] or with mitochondria [7, 8] . Its molecular identity as NAT8L (Nacetyltransferase 8-like) has only recently been established [9, 10] through generation of the recombinant protein and demonstration of its aspartate N-acetyltransfease activity. A homozygous 19 bp deletion in exon 1 of the NAT8L gene was found in the only patient known be deficient in N-acetylaspartate [9] , confirming this molecular identity. Confocal microscopy studies indicated that recombinant NAT8L was localized to the ER (endoplasmic reticulum), both in transfected CHO (Chinese-hamster ovary) cells and in lentivirus-tranduced primary neurons. However, the determinants of its association with the ER and the orientation of its catalytic site (cytosolic or luminal) remain unknown. The related human enzyme, NAT8 (N-acetyltransferase 8), which shares approximately 30 % sequence identity with NAT8L and is expressed in kidneys and liver, was shown to catalyse the acetylation of cysteine-S-conjugates and to be also associated with the ER [11] , consistent with the previous subcellular localization of this enzymatic activity [12] . No consensus has yet been reached on the subcellular localization of NAT8L, as Ariyannur et al. [8] reported a partial mitochondrial localization of the endogenous protein in SH-SY5Y cells, using antibodies directed against NAT8L peptides.
The purpose of the present study was to determine which regions of recombinant NAT8L are important for its catalytic activity and its subcellular localization. Furthermore, we also aimed to determine the orientation of its catalytic site with respect to the cytosol.
MATERIALS AND METHODS

Preparation of plasmids and site-directed mutagenesis
Experimental details for the preparation of plasmids and the sequences of the primers used for site-directed mutagenesis and for constructing GFP (green fluorescent protein)-fusion proteins are available in the Supplementary Online Data at http://www.BiochemJ.org/bj/441/bj4410105add.htm.
Expression in HEK (human embryonic kidney)-293T cells and analysis by Western blotting
HEK-293T cells were cultured and transfected essentially as described by Rzem et al. [13] using the jetPEI TM procedure. After incubation for 48 h at 37
• C, cells were washed once with 5 ml of ice-cold PBS, scraped in 0.8 ml of extraction buffer (20 mM Hepes, pH 7.1, 5 μg/ml leupeptin and 5 μg/ml antipain), frozen in liquid nitrogen, thawed and lysed by vortex-mixing. The extracts were incubated for 1 h on ice with 100 units/ml DNase I (Sigma-Aldrich) prepared in 5 mM MgSO 4 before use. Protein concentration was determined with the Bradford assay [14] , using γ -globulin as a standard.
To compare and quantify expression of wild-type and mutant NAT8L, Western blots were carried out in quadruplicate with similar amounts (40-80 μg of protein) of cell extracts containing the different forms of NAT8L. The PVDF membranes (Millipore) were blocked with PBS containing 5 % (w/v) non-fat dried skimmed milk during 1 h at 37
• C, and incubated overnight at 4
• C with a monoclonal anti-His 6 antibody (PentaHis antibody, Qiagen) diluted 1:2000 in PBS containing 1 % (w/v) BSA. The membranes were washed four times during 5 min in PBS/0.1 % Tween 20 before incubation with Odyssey Blocking Buffer (LI-COR) containing 0.02 % SDS, 0.1 % Tween 20 and IRdye 680-conjugated anti-mouse antibodies diluted 1:5000 (LI-COR). Membranes were scanned (Odyssey Infrared Imager; LI-COR) and the intensity of the fluorescence of each band was measured and expressed relative to the amount of the wild-type NAT8L band.
Assay of aspartate N-acetyltransferase activity
Activity of wild-type and mutated forms of NAT8L was generally assayed radiochemically as described by Wiame et al. [9] . The same test was used to determine the K m value for both substrates. Mutants with lesser affinity were assayed with a DTNB [5,5 -dithiobis-(2-nitrobenzoic acid)]-based test, in a mixture (0.2 ml) comprising 10 mM potassium phosphate (pH 7.1), 20 mM Hepes, 1 mM MgCl 2 , 0.5 mM CHAPS, 0.2 mM acetyl-CoA and 1 mM L-aspartate. The kinetic parameters were determined with various concentrations of aspartate and acetyl-CoA. Samples of 10 μl of total extracts of transfected HEK-293T cells were added to initiate the reaction, which was stopped by the addition of 1 mM DTNB solution after 30 min at 30
• C. Absorbance at 415 nm was measured in a microplate reader (Bio-Rad Laboratories).
Phosphorylation of a tag specific for PKA (cAMP-dependent protein kinase)
The Gly-Cys-Gln-Arg-Arg-His-Thr-Leu-Pro-Ala-Ser-Glu-Phe sequence from serotonin N-acetyltransferase was inserted by PCR in region 2 and at the C-terminus of NAT8L-pEF6MycHisA, as well as just four amino acids residues before the C-terminal KDEL sequence of DsRed2-ER (Clontech). The PCR mixture and conditions were the same as above, except that the extension time with pDsRed2-ER as a template was 6 min. HEK-293T cells were transfected with these constructs using the jetPEI TM procedure, as described in the Supplementary Online Data. Half of the dishes containing HEK-293T cells were incubated with 20 μM forskolin (Sigma-Aldrich) during 20 min before lysis. For each construct, total extracts of cells that had not been treated with forskolin were also phosphorylated in vitro with 20 μg/ml catalytic subunit of PKA (Calbiochem) in the presence of 500 μM ATP, 25 mM Hepes (pH 7.2), 1 mM DTT (dithiothreitol) and 1 % Triton X-100 for 30 min at 30
• C. Total extracts of cells treated or not with forskolin and total extracts submitted to in vitro phosphorylation were analysed by Western blotting using the same protocol as described above for the quantification of NAT8L. The chimaeric phosphoproteins were detected in parallel with a primary rabbit anti-(phospho-serotonin N-acetyltransferase) (p-Thr 29 ) antibody (1:2000; Sigma-Aldrich) and secondary IRdye 800-conjugated anti-rabbit antibodies (1:5000; LI-COR).
Confocal microscopy
CHO cells were propagated in a DMEM (Dulbecco's modified Eagle's medium)/Ham's F12 mixture (1:1) supplemented with 10 % (v/v) FBS (fetal bovine serum) and antibiotics (100 units/ml penicillin and 100 μg/ml streptomycin). They were seeded at 50 000 cells/cm 2 in 24-well plates on glass coverslips coated with 25 μg/μl fibronectin for fixed-cell imaging or in Labtek II (Nunc) for live-cell imaging, and grown for 1 day to ∼ 80 % confluence. Cells were transfected in OptiMEM medium with a DNA/Lipofectamine TM (Invitrogen) ratio of 1:2. After incubation for 5 h at 37
• C, the transfection medium was removed and cells were incubated overnight in DMEM/Ham's F12 with 10 % (v/v) FBS without antibiotics.
For the NAT8L-pEF6MycHisA constructs, a total DNA amount of 0.5 μg was used and cells were processed for immunofluorescence after 24 h as described by Mettlen et al. [15] . Primary antibodies were mouse IgG2a anti-Myc (9B11) monoclonal antibody (1:500; Cell Signaling Technology) or rat monoclonal antibody recognizing KDEL-bearing proteins (1:300; Abcam). Alexa Fluor ® -labelled secondary antibodies (Molecular Probes) were used at 5 μg/ml. All preparations were mounted in Mowiol in the dark overnight and examined by confocal microscopy using the COSD (confocal observer spinning disc) Zeiss platform equipped with a 100× objective at a laser power not exceeding 30 % and settings excluding saturation background.
For live-cell imaging, transfections with NAT8L-pEGFP-C1 or NAT8L-pAcGFP1-N3 (fusion proteins) and with pDsRed2-ER (ER marker) were carried out with 1.5 μg of total DNA, and cells were observed directly under the confocal microscope. For mitochondrial labelling, cells were incubated with 200 nM MitoTracker Red (CMXRos; Molecular Probes) in DMEM/Ham's F12 for 20 min at 37
• C and then in MitoTrackerfree medium for 30 min at the same temperature.
RESULTS
Multiple alignment of NAT8L sequences
On the basis of sequence conservation and hydrophobicity, we have divided NAT8L into five regions (Figure 1 ). An N-terminal 40-residue region (region 1) is highly conserved among NAT8Ls (see the legend to Figure 1 for values of conservation and hydrophobicity indices [16] ). This region is followed by a poorly conserved proline-and alanine-rich region of variable length (region 2). Region 3 (∼ 30 residues) and region 5 (∼ 150 residues), which are highly conserved, are separated by a hydrophobic region of ∼ 30 residues (region 4), which possesses in its middle a small cluster of polar residues. Figure 1 also shows that regions 3, 4 and 5 of NAT8L align with NAT8, a membrane-bound enzyme of the ER that catalyses the acetylation of cysteine-S-conjugates [11] . Only regions 3 and 5 align with Bacillus subtilis PaiA, a bacterial protein which catalyses the acetylation of spermine and spermidine, and the structure of which is known [17] . The long hydrophobic region (region 4) found in NAT8L and NAT8 is replaced by a small loop between helices αA and αB in the structure of PaiA. The lack of the hydrophobic region in PaiA, a soluble bacterial protein, suggests that region 4 could be important for the association of NAT8L and NAT8 with membranes.
Role of the different regions in catalysis
Aspartate N-acetyltransferase is a membrane-bound enzyme that cannot be purified in an active form because of its sensitivity to high concentrations of detergents. To evaluate the effect of different mutations on the activity of this enzyme, all mutated proteins that we produced by transfection of HEK-293T cells comprised both an Myc tag and a poly-His tag at the C-terminus. The poly-His tag was used to quantify the relative amount of recombinant protein by fluorescence Western blotting. All activity measurements were corrected for expression levels by comparing the intensity of the mutated NAT8L band with that of the wild-type enzyme.
We first investigated the role of regions 1 and 2 by creating a series of deletion mutants encompassing up to residue 68. Western blot analyses confirmed that the expressed proteins had the expected sizes ( Figure 2A ). Aspartate N-acetyltransferase activity measurements revealed no difference in activity in the deletion mutants for the first 7, 14 or 37 amino acids, indicating that region 1 is not involved in the catalytic activity. The mutant starting from residue 68 had a somewhat lower activity ( Figure 2B ), yet no significant change was observed in its K m values for Laspartate and acetyl-CoA (results not shown). Thus regions 1 and 2 appeared to be dispensable for enzymatic activity.
To study the role of regions 3 and 5 in catalysis, we created point mutants in which highly conserved residues (i.e. conserved in both NAT8L and NAT8) were replaced either conservatively or non-conservatively. As shown in Table 1 , the mutations that affected the activity most were those introduced in region 5: replacement of Asp 168 by glutamate or alanine cancelled the activity, whereas replacement of Arg 220 by lysine or alanine increased the K m values for both substrates ∼ 20-and ∼ 40-fold in the case of the conservative and non-conservative substitutions respectively. In comparison, the effects of the mutations in region 3 were moderate, although significant for the non-conservative substitutions: the K m value for aspartate was increased 2-and 4-fold in the R81A and E101A mutants respectively, and the K m value for acetyl-CoA was increased 8-and 12-fold for the same two mutants. These findings indicated that not only region 5, but also region 3 is involved in catalysis.
Importance of the membrane region
We also performed several point mutations in the hydrophobic region (region 4), which, as shown below, anchors NAT8L to the membrane. Several residues are conserved or semi-conserved in NAT8Ls, but not in NAT8. These include a central basic residue (Arg 133 ) flanked by a serine residue (Ser 132 ), two cysteine residues (Cys 128 and Cys 139 ) and a proline residue (Pro 142 ). Mutations of these residues to alanine barely affected the activity, except for the mutation of Arg 133 , which decreased it by 40 % on its own and by 60 % when combined with a mutation affecting the neighbouring serine residue (Ser 132 ) ( Table 2) . Secondary-structure predictions with JPred3 [18] indicated that the membrane region contains two α-helices comprising Ala 117 -Phe 129 and Leu 137 -Leu 146 respectively. We anticipated therefore that addition of one, two, three or four residues in these segments would rotate region 3 relative to region 5 by 100
• , 200
• , 300
• and 400
• , leading to loss of activity when the angle (e.g. 200
• ) is poorly compatible with proper association of the two regions in a single catalytic domain. This prediction was fully verified Table 2 Effect of mutations in the membrane region (region 4) on the catalytic activity of NAT8L
The same general procedure was used as for Figure 2 and for the constructions in which leucine residues were added in the second part of the membrane region: addition of two leucine residues affected the activity more than did addition of one or three leucine residues, whereas addition of four leucine residues had no significant effect (Figure 3 ). The picture was somewhat more complicated when the leucine residues were added in the first part of the membrane region: addition of one or two leucine residues led to 50 % and 100 % loss of activity, whereas addition of three leucine residues led to its full recovery ( Figure 3) . However, addition of four leucine residues led also to a complete loss of activity, which may indicate that the first helix of the membrane region becomes then too long for correct assembly of regions 3 and 5.
Topology of NAT8L
The results mentioned above indicated that regions 1, 2, 3 and 5 are on the same side of the membrane of the ER, but did not allow us to assign a luminal or cytosolic orientation for these regions. To answer this question, we engineered NAT8L to include a peptide (from serotonin N-acetyltransferase) that can be phosphorylated by PKA, either at the C-terminus of the protein or into region 2. Should this peptide be exposed to the cytosol, it would be phosphorylated in a cAMP-dependent manner by PKA, but not if the peptide is luminal. The constructs were transfected in HEK-293T cells, which were treated or not with forskolin, an agent that increases the concentration of cAMP. Extracts were prepared and immediately analysed by Western blotting with antiphosphopeptide and anti-(poly-His tag) antibodies. NAT8L was found to be phosphorylated when the sequence of serotonin Nacetyltransferase had been inserted in region 2 or at the C-terminus of NAT8L (Figure 4 ). This phosphorylation was increased, mostly for the C-terminal insertion (∼ 7-fold, as determined by quantification of the fluorescence signal), but also reproducibly for the other construction (1.9-fold), if the cells had been treated with forskolin. As shown in Figure 4 (C), the phosphorylation observed with extracts of forskolin-treated cells amounted to ∼ 80 % and ∼ 40 % of those observed when extracts of transfected cells were treated in vitro with the catalytic subunit of PKA and ATP to obtain full phosphorylation of the chimaeric proteins. No phosphorylation was observed if the phosphorylatable peptide was absent from NAT8L. To verify that no cAMP-dependent phosphorylation would occur for a protein restricted to the ER lumen, we transfected HEK-293T cells with DsRed2-ER, an RFP (red fluorescent protein) bearing a signal peptide and a KDEL-based ER-selective signal, to which we had added the same phosphorylatable tag as for NAT8L. A faint phosphorylation signal was observed at the level of DsRed2-ER, which was not significantly increased in cells that had been treated with forskolin. As shown in Figure 4 (C), this signal amounted under both conditions to ∼ 6 % of the signal
Figure 4 Cytosolic orientation of region 2 and the C-terminus of NAT8L, as demonstrated with a phosphorylatable tag
A 13-residue tag comprising a phosphorylation site for PKA (derived from serotonin N-acetyltransferase) was inserted either in region 2 (R2) or at the end of region 5 (C-terminus) of NAT8L (see Figure 1) , or just before the C-terminal KDEL signal of DsRed2-ER, an artificial protein targeted to the ER. At 48 h after transfection with these constructs, HEK-293T cells were treated with 20 μM forskolin or vehicle (DMSO) for 20 min before lysis. Equal amounts of cell extract protein were analysed by Western blotting using rabbit antibodies directed against the phosphorylated tag and green-fluorescence-labelled anti-rabbit antibodies (A), as well mouse anti-His 6 antibodies and red-fluorescence-labelled anti-mouse antibodies (B). Molecular masses are indicated in kDa. The signals corresponding to the phosphorylated peptides were quantified by Western blotting (C). The 100 % value was obtained by incubating the different transfected cell extracts with the catalytic subunit of PKA, 1 mM ATP and Triton X-100 for 30 min to fully phosphorylate the different chimaeric proteins (not shown). The arrow labelled 'DsRed2-ER' in (A) shows the position of transfected DsRed2-ER, which appears as a faint band here, but as a strong band after in vitro phosphorylation of cell extracts in the presence of Triton X-100 (not shown). Results are means + − S.E.M. for n = 3 experiments.
observed at the same position in the blot when an extract of cells expressing modified DsRed2-ER had been treated in vitro with the catalytic subunit of PKA and ATP in the presence of Triton X-100 to fully phosphorylate the chimaeric DsRed2-ER protein.
Taken together, these results indicated that both region 2 and the C-terminus of NAT8L are on the cytosolic side of the ER membrane.
Determinants of the subcellular localization
The subcellular localization of all mutants mentioned above was determined by confocal microscopy using antibodies directed against the Myc tag present at the C-terminus of all NAT8L constructs. All mutants mentioned above were found to be associated with the ER similarly to wild-type NAT8L. This was the case not only for the point mutants in regions 3, 4 and 5, but also for the truncated mutants starting at Met 8 , Met 15 , Met 38 or Met 68 . These findings are exemplified for a few of the constructs in Supplementary Figure S1 at http://www.BiochemJ. org/bj/441/bj4410105add.htm.
To evaluate further which regions of the protein are involved in its targeting to the ER, we cloned part or the whole of the sequence of NAT8L in vectors allowing its expression as a fusion protein with GFP. In this way, we generated 11 constructs in which we had the complete NAT8L sequence, or portions of it (regions 1 and 2; only region 1; regions 3-5; regions 3 and 4; only region 4) fused to the N-or the C-terminus of GFP. These constructs were transfected in CHO cells and living cells were analysed by confocal microscopy ( Figures 5 and 6 ). When GFP alone was transfected, cells showed a rather homogeneous fluorescence in the cytosol and in the nucleus, except for nonfluorescent spots corresponding to the mitochondria and to the nucleolus ( Figures 5A and 5B) . GFP fused to the whole NAT8L sequence was detected in the nuclear membrane and exhibited a reticular pattern in the perinuclear region ( Figures 5C and 5D ), as described previously for NAT8L recognized with anti-Myc antibodies [9] . As with the NAT8L-Myc fusion [9] , there was a significant, but not perfect, co-localization of the chimaeric NAT8L-GFP constructs with an ER marker, either DsRed2-ER protein (Figure 6 ) or proteins recognized with anti-KDEL antibodies (results not shown). The lack of perfect co-localization can be tentatively assigned to heterogeneity of the ER. We consistently found that the pattern observed with the chimaeric GFP-NAT8L constructs was markedly different from the pattern observed with mitochondrial staining with MitoTracker Red ( Figure 6 ; and results not shown). Partial superposition of the two signals was exceptionally observed, which was most likely to be the result of superposition of mitochondria and ER in the same optic section. Similar findings were made whether GFP was fused upstream or downstream of the NAT8L sequence.
Fusion of GFP to region 1 ( Figures 5E and 5F ) or to regions 1 and 2 ( Figures 5G and 5H ) led to proteins that localized, similarly to GFP alone, in the cytosol and the nucleus (Figures 5E-5H) . Interestingly, all other constructs, which comprised regions 3-5 ( Figures 5I and 5J) , regions 3 and 4 (results not shown) or only region 4 ( Figures 5K, 5L , 6C and 6D) fused to GFP gave similar results to those of the full-length protein, indicating that region 4, i.e. the membrane domain, is sufficient to target NAT8L to the ER ( Figure 6 ). Of note, none of these constructs co-localized with MitoTracker. Figure 7 is a proposed model for the architecture of NAT8L, most particularly for its association with the ER membrane. In this model, we show the structure of B. subtilis PaiA, a typical member of the N-acetyltransferase family [17, 19, 20] , in which we have coloured the residues that align with regions 3 and 5 of NAT8L mauve and green respectively. According to this scheme, the catalytic domain of NAT8L is composed of regions 3 and 5. Region 3 essentially contributes the most N-terminal β-strand, at one extremity of the V-shaped β-sheet common to Nacetyltransferases of the Gcn5 (general control non-derepressible 5) family [19] , as well as helix αA, which occupies a groove between β-strands 2, 3 and 4, and α-helices B and C. Compared with soluble N-acetyltransferases, the insertion of 30 hydrophobic residues between helices αA and αB has created an (inverted-)Ushaped membrane domain, corresponding to region 4 (yellow). This hydrophobic region, which comprises two helical segments, determines not only the association of NAT8L with membranes, but also its subcellular localization (see below). The catalytic site is delineated essentially by residues of region 5 (β-strands 4 and 5; helix αD), but also by the C-terminus of helix αA. The highly conserved region 1 (not depicted in the model) is not involved in forming the catalytic site. It is most likely to be loosely connected to the bulk of the protein by the highly variable proline-and alanine-rich region 2 (results not shown). We postulate also that NAT8, i.e. cysteine-S-conjugate N-acetyltransferase [11] , has the same architecture as regions 3-5 in NAT8L.
DISCUSSION
General architecture of NAT8L
Experimental support for this model was obtained with our mutagenesis experiments, indicating that both regions 3 and 5 (although not regions 1 and 2) contribute to forming the catalytic site. These findings also imply that the hydrophobic domain forms a loop in the membrane. That this loop comprises helical segments is indicated by the leucine-addition experiments, showing that the relative orientation of regions 3 and 5 in space is critical for their proper association into a functional catalytic site. The This cartoon, based on the structure of the bacterial protein PaiA [17] , aims to visualize the localization of the loop (yellow), which is lengthened and highly hydrophobic in NAT8L, causing its association with the ER membrane. The residues of PaiA that align with regions 3 and 5 are coloured mauve and green respectively (same colour code as in Figure 1) . Some of the helices and β-strands of PaiA are indicated and the CoA molecule present in its catalytic site is shown in red. Regions 1 and 2 of NAT8L, which do not align with PaiA, are not shown.
presence of a membrane loop between two subregions of the catalytic domain also accounts for the well-known sensitivity of aspartate N-acetyltransferase to high concentrations of detergents [5, 9] . Disruption of the lipid bilayer is likely to disorganize the hydrophobic loop between helix αA and αB, thereby affecting the structure of the catalytic site and/or the structure of the whole catalytic domain.
The catalytic site is cytosolic
The experiments in which a phosphorylation site was introduced into two different positions of NAT8L clearly indicated that regions 2 and 5 (and therefore also regions 1 and 3) are on the cytosolic side of the ER membrane, leading therefore to the conclusion that the catalytic site is cytosolic. A similar conclusion had previously been drawn for cysteine-S-conjugate N-acetyltransferase (i.e. NAT8) on the basis of protease sensitivity of this enzyme in microsomes derived from kidney and liver [12] . Subcellular targeting prediction programs (TargetP and PsortII) indicate that neither NAT8L nor NAT8 has a signal peptide. This is indicated further in the case of NAT8L by the finding that its Nterminus is not processed when NAT8L is expressed in eukaryotic cells. We reported previously that constructs in which the Nterminus is tagged conserved this tag [9] . Furthermore, we show in the present work that C-terminal tagged constructs in which the N-terminus had undergone progressive deletions appeared in Western blots as discrete bands with the expected sizes. This would not be the case if an N-terminal signal peptide had been removed. It is therefore likely that both NAT8L and NAT8 are synthesized on free ribosomes and that they secondarily attach to the ER membrane via their membrane loop.
The close association of NAT8L with the membrane raises the question of the advantage of this arrangement. Association with the membrane may confer sensitivity to lipid molecules. Alternatively, it may be a remnant of evolution, if one assumes that NAT8L is derived from NAT8 (i.e. cysteine-S-conjugate N-acetyltransferase). The latter enzyme indeed uses substrates that have a hydrophobic portion and are most probably highly concentrated at the membrane surface. Having the catalytic site closely associated with the membrane may be advantageous for an enzyme acting on this category of substrates. This is true also for glucuronosyltransferases, which are closely associated with the membrane of the ER and conjugate hydrophobic molecules. In this case, however, the catalytic site is luminal [21, 22] .
Determinant of the subcellular localization
As mentioned in the Introduction, the subcellular localization of aspartate N-acetyltransferase is a matter of controversy. Subcellular fractionation experiments performed on brain extracts suggested a dual microsomal and mitochondrial localization [6] , with the highest enzyme specific activities found in the microsomal fraction. Immunostaining of SH-SY5Y cells with antibodies directed against an NAT8L peptide indicated partial mitochondrial localization and partial localization to undefined structures in the cytoplasm [10] . Noticeably, the patterns of mitochondrial staining with MitoTracker and with the anti-NAT8L peptide antibody were substantially different, which may cast some doubt on this mitochondrial localization. Thus whether this dual localization of aspartate N-acetyltransferase/NAT8L is real or due to artefacts (e.g. difficulties of fractionating such a heterogeneous tissue as brain; problems of specificity of antibodies) is not clear at present.
What is clear, however, is that the enzyme that we express in CHO cells or in neurons ( [9] and the present study) is exclusively associated with the ER, with no indication of association with mitochondria. This ER localization presumably corresponds to the 'microsomal' form of enzyme found in the fractionation studies. We are therefore able to study only the determinants of this subcellular localization.
Dissection of NAT8L indicates that the N-terminal region does not play any role in the subcellular localization. Furthermore, association with the ER was observed with all constructs that were tested provided they contained the membrane region. This region thus appears necessary and sufficient to allow NAT8L to bind to membranes and to be associated with the ER. This is reminiscent of other ER proteins, which associate with its membrane via a Cterminal hydrophobic tail (Bcl2 [23] ; cytochrome b 5 [24] ). Like NAT8L, these proteins are devoid of signal peptide.
As for a potential mitochondrial localization of NAT8L, it is known that some forms of C-terminal hydrophobic tail cause the association with the mitochondrial outer membrane rather than with the ER membrane. This is the case for some species of cytochrome b 5 or Bcl-x L , a protein homologous with Bcl-2. The presence of an amphipathic helix and of positively charged residues on both sides of the membrane domain favour a mitochondrial localization compared with an ER localization [23] . Thus subtle differences could result in different targeting, either to the ER or the mitochondrial outer membrane. The absence of mitochondrial localization of NAT8L in the experiments reported in the present paper may be due to the lack of a cofactor or a covalent modification that helps NAT8L to be targeted to the mitochondria. It may be interesting to recall that aspartate Nacetyltransferase, as partially purified from brain, has an apparent molecular mass of ∼ 600 kDa by gel filtration [25] , suggesting its association with other proteins. However, the absence of any mitochondrial localization of NAT8L in transduced neurons in primary cultures [9] argues against this reservation, but again this may be due to a hypothetical cofactor being in insufficient amount in these cells.
From a physiological standpoint, it is important to resolve the question of the subcellular localization of aspartate Nacetyltransferase, not only to understand better the function of N-acetylaspartate (one of the theories is that the formation of N-acetylaspartate is involved in a mini-tricarboxylic acid cycle [1] ), but also to understand (and possibly prevent) the reversible lowering of the N-acetylaspartate concentration that is observed in diseases such as AIDS encephalopathy [26] , traumatic brain injury [27] and epilepsy [28] . Our own findings indicate that (at least) part of aspartate N-acetyltransferase is associated with the ER, with the catalytic site facing the cytosol. Its activity (at least of the form of enzyme that is associated with the ER) is therefore determined by the concentration of substrates and products that are present in the cytosol rather than in the lumen of the ER and possibly by lipid molecules that are present in the ER membrane.
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MATERIALS AND METHODS
Site-directed mutagenesis
As a rule, the pEF6MycHisA vector (50 ng) containing the human NAT8L sequence was used as a template in 50 μl of PCR mixture [containing 25 pmol of each primer (see Table S1 for primer sequences), 0.2 mM dNTP, 1 M betaine and 2.5 units of Pfu polymerase in 1 × Pfu buffer]. This mixture was subjected to thermal cycling at 96
• C for 30 s for denaturation, followed by 30 s at 55
• C for annealing and 8 min at 72 • C for extension. A total of 20 cycles was used, and the procedure was ended by 10 min at 72
• C. Three identical reactions were pooled, purified with the GeneJet TM PCR purification kit (Fermentas) and eluted with 35 μl of 10 mM Tris/HCl (pH 8.5). The purified PCR product was digested for 2 h at 37
• C with 20 units of DpnI in order to eliminate the template. A 10 μl sample of the digested PCR product was used to transform 60 μl of Escherichia coli XL1-Blue bacteria. The complete NAT8L coding region of all plasmids was sequenced to verify the presence of the introduced mutation and the absence of random mutations.
For the + 4Leu 124 (introduction of four leucine residues after Leu 124 ) and P142A constructs, we used the pBlueScript vector containing the NAT8L sequence as a matrix, Optimase polymerase (Transgenomic) and a hybridization temperature of 65
• C. For mutants with a truncation or supplementary leucine residue(s), 5 -phosphorylated primers were used in the PCR and the products were ligated overnight at 16
• C with 5 units of T4 DNA ligase (Fermentas) in the presence of 5 % (v/v) PEG [poly(ethylene glycol)] 4000 in 50 μl of 1 × ligase buffer, before DpnI restriction and transformation.
Fusion protein with GFP
For PCR-amplification of the different regions (R) of NAT8L (R1-R2, R4, R3-R4 and R3-R4-R5), we used the same mixture as above with forward primers containing an EcoRI or a BglII restriction site and reverse primers containing a BamHI or a SalI restriction site (see Table S1 for primer sequences). PCR cycles (30) were as follows: 96
• C for 30 s, 1 min at 60
• C and 1 min at 72
• C (2 min for full-length NAT8L). The procedure was ended by 10 min at 96
• C followed by a slow renaturation step (decrease of 1
• C/min from 80 • C to 20 • C). The PCR products corresponding to different fragments or to full-length NAT8L were digested with the appropriate restriction enzymes (EcoRI/BamHI or BglII/SalI) overnight at 37
• C. The plasmids pEGFP-C1 and pAcGFP1-N3 (Clontech) were digested with the same enzymes and dephosphorylated with alkaline phosphatase (Roche). Each fragment was ligated in pEGFP-C1 (GFP at the N-terminus) or in pAcGFP1-N3 (GFP at the C-terminus) as described above, and the resulting plasmids were used to transform E. coli XL1-Blue bacteria.
For fusion with region 1 of NAT8L, we performed a PCR with long primers directly containing the sequence of the fragment (see Table S1 ). The PCR mixture comprising 50 ng of pEGFP-C1 or pAcGFP1-N3, 1 μl of Optimase polymerase, 0.2 mM dNTP and 25 pmol of each primer was submitted to 25 cycles of 30 s at 94
• C, 1 min at 55 • C and 10 min at 72 • C, followed by 5 min of incubation at 72
• C.
